Home > Insider Trading > Filing (0001127602-22-002958)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
64803	Cvs Health Corp	CVS	Retail-Drug Stores And Proprietary Stores (5912)	050494040

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1472795	Alan Lotvin	One Cvs Drive Woonsocket RI 02895	Evp&President-Pharmacyservices	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-02-01	21,386	$102.26	82,727	No	4	M	Direct
Common Stock	Disposition	2022-02-01	21,386	$106.50	61,341	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option	Disposition	2022-02-01	21,386	$0.00	21,386	$102.26

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2016-04-01	2022-04-01	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	492	Indirect	By Children's Trusts
Common Stock (Restricted)	5,827	Direct
Stock Unit	29,851	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option	$104.82	2017-04-01	2023-04-01	27,395	27,395	Direct
Common Stock	Stock Option	$78.05	2018-04-03	2024-04-03	32,911	32,911	Direct
Common Stock	Stock Option	$62.21	2019-04-01	2025-04-01	22,541	22,541	Direct
Common Stock	Stock Option	$54.19	2020-04-01	2029-04-01	70,702	70,702	Direct
Common Stock	Stock Option	$58.34	2021-04-01	2030-04-01	140,797	140,797	Direct
Common Stock	Stock Option	$74.30	2022-04-01	2031-04-01	120,940	120,940	Direct
Common Stock	Phantom Stock Credits	$1.00			557	557	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2023-04-01	27,395	27,395	Direct
2024-04-03	32,911	32,911	Direct
2025-04-01	22,541	22,541	Direct
2029-04-01	70,702	70,702	Direct
2030-04-01	140,797	140,797	Direct
2031-04-01	120,940	120,940	Direct
	557	557	Direct

Footnotes

All sales were effected pursuant to a Rule 10b5-1 plan.
Option became exercisable in four equal annual installments, commencing 4/1/2016.
Option became exercisable in four equal annual installments, commencing 4/1/2017.
Option became exercisable in four equal annual installments, commencing 4/3/2018.
Option became exercisable in four equal annual installments, commencing 4/1/2019.
Option became exercisable in four equal annual installments, commencing 4/1/2020.
The number of shares subject to the option were calculated using a 30-day average price.
Option became exercisable in four equal annual installments, commencing 4/1/2021.
Option becomes exercisable in four equal annual installments, commencing 4/1/2022.
Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.